El Corte Inglés funds breast cancer relapse research

El Corte Inglés has committed 400,000 euros over the next four years to fund a new research project aimed at understanding why breast cancer often recurs after initial treatment. The initiative is a collaboration with the Spanish Association Against Cancer (AECC).

Led by Dr. Ángela Nieto at the Institute of Neurosciences in Alicante, the study focuses on cellular plasticity. Researchers aim to investigate how tumor cells survive therapy by changing their identity to continue multiplying, a mechanism that allows them to develop resistance to treatments.

By using advanced technologies to analyze tumors on a cell-by-cell basis, the team seeks to identify the mechanisms behind this adaptation. The ultimate goal is to develop new therapeutic targets to prevent relapses in aggressive forms of the disease, such as triple-negative breast cancer and ovarian cancer.